Fan et al. (2012) [135] observed that LASS2 (Homo sapiens longevity assurance homolog 2 of yeast LAG1) is able to enhance breast cancer chemosensitivity by counteracting the acidic tumor microenvironment by inhibiting proton pump V-ATPase activity. Here, CERS2 is linked to breast cancer.